Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…
The post Finding and Evaluating Generic Drug Market Entry Opportunities appea…
Finding and Evaluating Generic Drug Market Entry Opportunities Read Post »
This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report our experience working with the US Food and Drug Administration…
The post Freedom of Information Act Access to an Investiga…
Freedom of Information Act Access to an Investigational New Drug Application Read Post »
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics on September 30th.…
The post Finding and Evaluating Generic Market Entry Opportun…
Finding and Evaluating Generic Market Entry Opportunities Read Post »
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. [email protected] Although it has become harder to obtain patent-term extensions for drugs, pesticides or agricultural chemicals, a careful…
The post Getting the…
Getting the most out of pharmaceutical patent-term extensions in Russia Read Post »
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…
The post Switching to DrugPatentWatch appeared fir…
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…
The post Government as the First Investor in B…
Government as the First Investor in Biopharmaceutical Innovation Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris J.J. Mulder in Drug Discovery Today under a Creative Commons…
The post Finding hidden treasures in old drugs: the challenges an…
This article was originally published by Mahendra Saini, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma in the Asian Journal of Pharmaceutical Research and Development. 2020; 8(4): 194-212 under an…
The post Drug Repurposing: An Overview appear…